Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200025, China.
Department of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Nat Commun. 2021 Nov 17;12(1):6653. doi: 10.1038/s41467-021-27048-3.
BRCA1-BARD1 heterodimers act in multiple steps during homologous recombination (HR) to ensure the prompt repair of DNA double strand breaks. Dysfunction of the BRCA1 pathway enhances the therapeutic efficiency of poly-(ADP-ribose) polymerase inhibitors (PARPi) in cancers, but the molecular mechanisms underlying this sensitization to PARPi are not fully understood. Here, we show that cancer cell sensitivity to PARPi is promoted by the ring between ring fingers (RBR) protein RNF19A. We demonstrate that RNF19A suppresses HR by ubiquitinating BARD1, which leads to dissociation of BRCA1-BARD1 complex and exposure of a nuclear export sequence in BARD1 that is otherwise masked by BRCA1, resulting in the export of BARD1 to the cytoplasm. We provide evidence that high RNF19A expression in breast cancer compromises HR and increases sensitivity to PARPi. We propose that RNF19A modulates the cancer cell response to PARPi by negatively regulating the BRCA1-BARD1 complex and inhibiting HR-mediated DNA repair.
BRCA1-BARD1 异二聚体在同源重组 (HR) 过程中发挥多种作用,以确保 DNA 双链断裂的及时修复。BRCA1 通路功能障碍增强了聚(ADP-核糖)聚合酶抑制剂 (PARPi) 在癌症中的治疗效果,但这种对 PARPi 的敏感性的分子机制尚不完全清楚。在这里,我们表明,癌症细胞对 PARPi 的敏感性受到环指之间环 (RBR) 蛋白 RNF19A 的促进。我们证明 RNF19A 通过泛素化 BARD1 来抑制 HR,导致 BRCA1-BARD1 复合物解离,并暴露出 BARD1 中的核输出序列,否则该序列被 BRCA1 掩盖,导致 BARD1 输出到细胞质。我们提供的证据表明,乳腺癌中高表达的 RNF19A 会损害 HR 并增加对 PARPi 的敏感性。我们提出,RNF19A 通过负调控 BRCA1-BARD1 复合物和抑制 HR 介导的 DNA 修复来调节癌细胞对 PARPi 的反应。